LA JOLLA, CA, April 30, 2024 – Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further...
Mike Grey will speak on "What Are the Funding Sources and How to Apply" at the American Chemical Society meeting in San Diego, CA
News | 10. 09. 2010
